Find your next paid study

Endometrial CancerEndometrioid AdenocarcinomaEndometrial Cancer Stage I

~$10 – $7,500

NRG OncologyNCT04251052

SEntinel Lymph Node Endometrial Cancer Trial: A Prospective Multicenter International Single-Arm Observational Trial (SELECT)

This study is being done to find out how often endometrial cancer recurs after the standard treatment as well as how often the standard treatment results in a …

Memorial Sloan Kettering Cancer CenterNCT04291612

~$10 – $750

Phase 3

A Phase III Trial Of The Impact Of Sentinel Lymph Node Mapping On Patient Reported Lower Extremity Limb Dysfunction In Endometrial Cancer

This phase III trial compares the effect of sentinel lymph node mapping to standard lymph node dissection in reducing the risk of swelling in the legs (lymphed…

Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)

~$10 – $7,500

NRG OncologyNCT05646316

Phase 1

Dosimetry and Bio-distribution of 203Pb-RMX-VH-PIB in Newly Diagnosed or Recurrent Patients With Solid Tumors: A Phase I Exploratory Study

The goal of this Phase I clinical trial is to evaluate how the imaging drug 203Pb- RMX-VH-PIB distributes in the body and how much radiation different organs r…

Radiomedix, Inc.NCT07733674

~$10 – $8,750

Observational

Prospective Single-Center Randomized Study Of Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound (HIFU)

This study aims to compare the novel single-port robotic partial prostatectomy to High-intensity focused ultrasound (HIFU) in patients with low to intermediate…

Prostate AdenocarcinomaProstate Cancer

Case Comprehensive Cancer CenterNCT05610852

Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8

Vorinostat to Augment Response to 177Lutetium-PSMA-617 in the Treatment of Patients With PSMA-Low Metastatic Castration-Resistant Prostate Cancer

This phase II trial tests how well vorinostat works in treating patients with prostate-specific membrane antigen (PSMA)-low castration-resistant prostate cance…

Fred Hutchinson Cancer CenterNCT06145633

Observational

Accuracy and Effect of Prescribed Generative AI Patient Education Module Within Breast Oncology Care

This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for b…

Breast CancerMetastatic Breast CancerCarcinoma of the Breast

University of California, San FranciscoNCT07512271

~$10 – $5,625

Malignant Neoplasm of BladderMuscle Invasive Bladder Carcinoma

Phase II Trial on the Safety and Efficacy of Partial Cystectomy and Extended Pelvic Lymph Node Dissection With Standard of Care Perioperative Systemic Therapy in the Management of Muscle-Invasive Bladder Cancer (PRESERVE Trial)

The goal of this clinical trial is to determine if a partial cystectomy with extended pelvic lymph node removal will be effective at treating Muscle-Invasive B…

Case Comprehensive Cancer CenterNCT06290687

Observational

An Interventional Study of PET/CT Changes During Chemoimmunotherapy and Radiation Therapy for Patients With Metastatic NSCLC (PET Bright)

This study investigates the changes in positron emission tomography (PET)/computed tomography (CT) imaging scans during chemoimmunotherapy and radiation therap…

Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8

University of WashingtonNCT04151940

Oral Squamous Cell CarcinomaOral CancerHead and Neck Cancer+1 more

A Phase II Single-arm Cohort Study Establishing the Effect of Antibiotic Treatment on Intratumoral Bacteria in Surgical Patients With Oral Cancer

The goal of this phase II single arm clinical study is to evaluate the effect of antibiotics (metronidazole) and oral chlorhexidine (CHX) in reducing the bacte…

Case Comprehensive Cancer CenterNCT06627270

Phase 1

Characterizing the Theranostic Potential of DLL3-targeting Agents in High-grade Neuroendocrine Carcinomas of the Lung and Prostate

The purpose of this study is to find out whether 177Lu-DTPA-SC16.56 is a safe treatment for people with small-cell lung cancer or neuroendocrine prostate cancer

Neuroendocrine Tumor of the LungNeuroendocrine Carcinoma of LungNeuroendocrine Carcinoma+1 more

Memorial Sloan Kettering Cancer CenterNCT06941480

Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma

SMART-PANC: SMAD4 Tailored Neoadjuvant Therapy for Pancreatic Cancer, A Phase ll Non-Randomized, Single Center Pilot Study

This phase II trial tests the impact of using SMAD4-mutant status to personalize chemotherapy in treating patients with pancreatic ductal adenocarcinoma (PDAC)…